FIELD: chemistry.
SUBSTANCE: invention relates to a compound which is 7-methyl-5-(3-piperazin-1-ylmethyl-[1,2,4]oxadiazol-5-yl)-2-(4-trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition having potentiating activity on glutamate receptors, containing the compound described above; also described is use of the compound or a pharmaceutically acceptable salt in claim 1 in producing a medicinal agent for therapy of neurological and mental disorders associated with glutamate dysfunction.
EFFECT: novel compound which can be used in therapy of neurological and mental disorders is obtained and described.
5 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDOLE AND BENZOXAZINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | 2009 |
|
RU2512283C2 |
| ISOINDOLE COMPOUNDS AND USE THEREOF AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATION FACTORS | 2005 |
|
RU2420517C2 |
| INDOLE AND BENZOMORPHOLINE DERIVATIVES AS MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS | 2009 |
|
RU2517181C2 |
| QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
| SUBSTITUTED DIHYDRO BENZOCYCLOALKYLOXYMETHYL OXAZOLOPYRIMIDINONE, PREPARING AND USING THEM | 2010 |
|
RU2543384C2 |
| SUBSTITUTED COMPOUNDS OF THIOPHEN AND FURAN-CONDENSED AZOLOPYRIMIDIN-5-(6H)-OH | 2013 |
|
RU2659779C2 |
| HETEROCYCLIC COMPOUNDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF DISEASES ASSOCIATED WITH METABOTHROPHIC GLUTAMATE RECEPTORS | 2000 |
|
RU2296127C9 |
| HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 RECEPTOR) | 2008 |
|
RU2479577C2 |
| POLYHETEROCYCLIC COMPOUNDS AND USE THEREOF AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | 2005 |
|
RU2381226C2 |
| DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
